Triethylamine → (+/-)-10-(3-(5-Cyanoisoxazol-3-yl)-3-hydroxybut-1-yn-1-yl)-9-fluoro-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxamide

HRID 575225Notes

Reaction equation

HRID 575225 reaction equation
[F:1][C:2]1[C:18]([C:19]#[C:20][C:21]([C:24]2[CH:28]=[C:27]([CH:29]=O)[O:26][N:25]=2)([OH:23])[CH3:22])=[CH:17][C:5]2[C:6]3[N:7]([CH:11]=[C:12]([C:14]([NH2:16])=[O:15])[N:13]=3)[CH2:8][CH2:9][O:10][C:4]=2[CH:3]=1.Cl.NO.C([N:36](CC)CC)C.CCN(CC)CC.CC(O)=O>CN(C)C=O.C(Cl)Cl>[C:29]([C:27]1[O:26][N:25]=[C:24]([C:21]([OH:23])([CH3:22])[C:20]#[C:19][C:18]2[C:2]([F:1])=[CH:3][C:4]3[O:10][CH2:9][CH2:8][N:7]4[CH:11]=[C:12]([C:14]([NH2:16])=[O:15])[N:13]=[C:6]4[C:5]=3[CH:17]=2)[CH:28]=1)#[N:36]

Participants

7

Conditions

Temperature
0 °C

Procedure

A solution of 9-fluoro-10-(3-(5-formylisoxazol-3-yl)-3-hydroxybut-1-yn-1-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxamide (90 mg, 0.22 mmol, 1.00 equiv), hydroxylamine hydrochloride (15 mg, 0.22 mmol, 1.00 equiv) in N,N-dimethylformamide (3 mL) was heated at 140° C. for 1 h. To this was added triethylamine (90 mg, 0.89 mmol, 4.00 equiv) at 0° C. To the mixture was added TEAA (70 mg, 1.50 equiv) dropwise with stirring at 0° C. The resulting solution was stirred for 12 h at 120° C. The reaction solution was diluted with DCM and washed with water. The crude product was purified by Prep-HPLC with the following conditions (1#-Pre-HPLC-005(Waters)): Column, XBridge Shield RP18 OBD Column, 5 um, 19*150 mm; mobile phase, Water with 10 mmolNH4HCO3 and CH3CN (15% CH3CN up to 70% in 10 min, up to 95% in 1 min, hold 95% in 1 min, down to 15% in 2 min); Detector, UV 254/220 nm. This gave the titled compound (5.4 mg, 6%).

Workup

  1. stirringThe resulting solution was stirred for 12 h at 120° C
  2. washwashed with water
  3. customThe crude product was purified by Prep-HPLC with the following conditions (1#-Pre-HPLC-005(Waters))
  4. waitup to 95% in 1 min
  5. customin 1 min
  6. waitdown to 15% in 2 min)

Sources & evidence

ORD record
ord-5cd72edba6384ac9ae12103dc2fc42de
Source dataset
uspto-grants-2015_05
Patent number
US09034866B2

Reaction notes

Loading…